Skip to content

Study · Not a test of the peptide alone · 2023

2 results

EFFECT OF INVESTIGATIONAL COMBINATIONS OF NEUROPROTECTANTS ON THE LEVEL OF S 100 AND NSE PROTEIN IN THE BLOOD SERUM OF PATIENTS WITH MODERATE AND SEVERE ISCHEMIC STROKE.

Karimulin R, Semenenko A

Georgian medical news1 Sept 2023

PMID37991949 (opens in a new tab)PepBankPUB-37991949
Publisher pageAsk about this study
Jump to 2 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone2

In this study, Cerebrolysin was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Cerebrolysin.

  1. 01HumanNot a test of Cerebrolysin aloneObservational studyEfficacy outcome

    In ischemic stroke patients, Cerebrolysin plus citicoline corrected neuroglioproliferative processes more effectively than conventional therapy.

    In plain wordsIn stroke patients, Cerebrolysin plus citicoline corrected neuroglioproliferative processes more effectively than conventional therapy.

    Peptide
    Cerebrolysin
    Outcome
    IncreaseCorrection of neuroglioproliferative processes
    Study

    n: not reported in source

    Comparator
    Conventional therapy
    Outcome group
    Neuroprotection · Nervous system and cognition

    Measurements

    Relative effectiveness
    1.7 to 2.7 times
    Versus conventional therapy
    P value for relative effectiveness in correction of neuroglioproliferative processes
    < 0.01
    Cerebrolysin plus citicoline versus conventional therapy

    Source sentences

    Summary
    Whereas, the use of a neuroprotective combination/complex (NPC) (cerebrolysin+citicoline) in the treatment of ischemic strokes in terms of the effectiveness of correction of neuroglioproliferative processes was 1,7-2,7 times (p<0.01) higher than conventional therapy

    In this study, Cerebrolysin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Cerebrolysin.

  2. 02HumanNot a test of Cerebrolysin aloneObservational studyEfficacy outcome

    In ischemic stroke patients, Cerebrolysin plus citicoline corrected neuroglioproliferative processes more effectively than Cerebrolysin plus mexidol.

    In plain wordsIn stroke patients, Cerebrolysin plus citicoline corrected neuroglioproliferative processes more effectively than Cerebrolysin plus mexidol.

    Peptide
    Cerebrolysin
    Outcome
    IncreaseCorrection of neuroglioproliferative processes
    Study

    n: not reported in source

    Comparator
    Cerebrolysin plus mexidol
    Outcome group
    Neuroprotection · Nervous system and cognition

    Measurements

    Relative effectiveness
    1.2 to 1.4 times
    Versus cerebrolysin plus mexidol
    P value for relative effectiveness in correction of neuroglioproliferative processes
    < 0.05
    Cerebrolysin plus citicoline versus Cerebrolysin plus mexidol

    Source sentences

    Summary
    and 1,2-1,4 times (p<0.05) higher than treatment that included the use of a neuroprotective combination - cerebrolysin+mexidol.
    1 context sentence
    Summary · context
    Whereas, the use of a neuroprotective combination/complex (NPC) (cerebrolysin+citicoline)

    In this study, Cerebrolysin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Cerebrolysin.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    14 Oct 2026, 05:02 UTC

    Study results updated

  2. Version 1

    14 Oct 2026, 01:46 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

Publication types

PepBank is a research reference. Talk to a doctor before you use any peptide.